Market Place
Sourcing Support
Mikart Adds Nitrogen-Purged Capability to Liquid and Suspension Suites
24 Oct 2024 //
PRESS RELEASE
Mikart and Nano PharmaSolutions complete key milestones
07 May 2024 //
PR NEWSWIRE
Mikart Announces Validation of Its New Liquid and Suspension Suite
12 Mar 2024 //
PRESS RELEASE
Mikart, LLC Expands Oral Solid Dose Manufacturing Capabilities
15 Feb 2024 //
PRESS RELEASE
Mikart buys FlexPack’s NF-150 Horizontal Sachet-Packaging machine
25 Sep 2023 //
PR NEWSWIRE
Mikart`s Generic Methocarbamol Receives Approval in the U.S.
12 Jun 2023 //
FDA
Mikart invests in liquids and suspensions suite to enhance oral drug product
31 Jan 2023 //
PRESS RELEASE
Mikart Partners with Fluid Pharma to Advance the Application of MicroCoat Technology
20 Oct 2022 //
PRESS RELEASE
Mikart and Nano PharmaSolutions Entered Collaboration
12 Oct 2022 //
PRESS RELEASE
Mikart continues to meet the growing demand for the development and manufacturing of controlled substances
01 Jun 2021 //
PRESS RELEASE
Nautic Partners Announces Acquisition of Mikart, Inc.; Michael Kallelis Appointed as CEO
26 Sep 2018 //
BUSINESSWIRE
Mikart Compliant with DSCSA Mandates
06 May 2017 //
CONTRACTPHARMA
Lupin Gets USFDA Nod for Generic Pain Relieving Drug
18 Nov 2016 //
ECONOMIC TIMES
Mikart`s Generic Butalbital:Acetaminophen Receives Approval In US
15 Nov 2016 //
FDA
Mikart`s Generic Chlorzoxazone Approved in US
24 Jun 2016 //
FDA
Mikart`s Carbinoxamine Maleate approved in US for Allergic Reactions
31 May 2016 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.